To amend chapter 89 of title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefits Program.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act''.
SEC. 2. IMPROVED PROGRAM INTEGRITY, TRANSPARENCY, AND COST SAVINGS FOR PRESCRIPTION DRUG BENEFITS IN THE FEDERAL EMPLOYEES HEALTH BENEFITS PROGRAM.
(a) Change in Contracting Requirements.--Section 8902 of title 5, United States Code, is amended by adding at the end the following: ``(p) A contract may not be made or a plan approved under this chapter, with respect to a carrier that is a party to a PBM carrier arrangement, unless the PBM and such carrier comply with the requirements of section 8915. The Office shall terminate such contract or discontinue such plan for failure to comply with such requirements.''. (b) Requirements for PBMs and Related Requirements for Carriers.-- Chapter 89 of title 5, United States Code, is amended by adding at the end the following: ``Sec. 8915. Requirements for PBM arrangements ``(a) Limitations on Cross-Ownership.-- ``(1) In general.--Under a PBM carrier arrangement a PBM may not be under common corporate control with-- ``(A) a prescription drug manufacturer; or ``(B) a retail pharmacy. ``(2) Profit restriction on corporately affiliated carriers and pbms.--With respect to a PBM carrier...